Scorpion Capital LLC
Ex parte reexamination requester·1 ex parte reexams
Scorpion Capital LLC has requested 1 USPTO ex parte reexamination. It most often challenges patents owned by Bioprojet. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
123
Top patent owners challenged
Outcome track record
How this requester's challenges resolve: claims confirmed, amended, mixed, or fully canceled.
- Certificate outcome split across every bucket
- Share of challenges that canceled claims
Challenge metrics
Cancellation rate, average pendency, and the open/closed split across every reexam this requester has filed.
- Outcome rate of closed challenges
- Average pendency in months
Examiners & defense counsel
Which examiners decide this requester's challenges, and which firms defend the targeted patents.
- Most frequent examiners
- Top opposing counsel
Recent reexaminations (1)
| Control # | Filed | Patent | Title | Owner | Status |
|---|---|---|---|---|---|
| 90/019,228 | Jul 19, 2023 | 8,207,197 | MONOHYDROCHLORIDE SALT OF 1-[3-[3-(4-CHLOROPHENYL) PROPOXY] PROPYL] -PIPERIDINE | Bioprojet | Closed |
See the full reexam picture for Scorpion Capital LLC
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.